17:16:10 EST Mon 16 Nov 2026
Enter Symbol
or Name
USA
CA



Eastwood Bio-Medical Canada Inc
Symbol EBM
Shares Issued 68,885,969
Close 2026-11-16 C$ 1.75
Market Cap C$ 120,550,446
Recent Sedar+ Documents

Eastwood amends FY 2025, Q3 FY 2026 results

2026-11-16 17:00 ET - News Release

Mr. Yunji Kim reports

EASTWOOD BIO-MEDICAL CANADA INC. ANNOUNCES REFILING OF ITS ANNUAL AND INTERIM MD&A

As a result of a review by the B.C. Securities Commission, Eastwood Bio-Medical Canada Inc. is issuing this press release to clarify its disclosure.

With respect to the company's annual management's discussion and analysis for the year ended Oct. 31, 2025, and its interim management's discussion and analysis for the nine-month period ended July 31, 2026, the BCSC has concluded that the affected filings lack sufficient discussion as per the requirements of Form 51-102F1. As a result, the company has amended and refiled the affected filings.

The affected filings clarify the company's supply and manufacturing arrangements, expand the disclosure of related-party relationships and balances, and strengthen the discussion of liquidity and financing needs. They also provide more detail on the factors affecting revenue and gross margin, add disclosure of recent strategic agreements, and make minor corrections and formatting updates throughout.

The amended and restated affected filings have been filed on SEDAR+. The amended and restated affected filings replace and supersede the corresponding financial statements and MD&A previously filed by the company. Readers should rely only on the amended and restated affected filings now available on SEDAR+.

© 2026 Canjex Publishing Ltd. All rights reserved.